CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 39 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,504 | +39.1% | 2,400 | +118.2% | 0.00% | – |
| Q2 2023 | $2,519 | +151.6% | 1,100 | 0.0% | 0.00% | – |
| Q1 2023 | $1,001 | – | 1,100 | +1000.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 100 | -90.9% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 1,100 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 1,100 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 1,100 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | +66.7% | 1,100 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 1,100 | +10.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,749,379 | $18,147,000 | 3.77% |
| VR Adviser, LLC | 3,427,461 | $16,589,000 | 2.13% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $15,854,000 | 2.04% |
| Telemetry Investments, L.L.C. | 196,168 | $949,000 | 1.28% |
| DC Investments Management, LLC | 50,709 | $245,000 | 0.46% |
| Orbimed Advisors | 6,943,654 | $33,607,000 | 0.37% |
| EcoR1 Capital, LLC | 2,081,077 | $10,072,000 | 0.35% |
| BVF INC/IL | 1,370,947 | $6,635,000 | 0.26% |
| Ikarian Capital, LLC | 757,545 | $3,666,000 | 0.26% |
| CHI Advisors LLC | 165,927 | $803,000 | 0.23% |